Ai2 and Providence Swedish Cancer Institute partner to advance AI-assisted scientific discovery
Allen Institute (AI2) 1 month ago 41
Ai2 partnered with the Paul G. Allen Research Center at the Providence Swedish Cancer Institute to run AutoDiscovery on cancer datasets. The collaboration analyzed The Cancer Genome Atlas (TCGA) and found a stronger immune signature in invasive lobular breast cancer, covering about 15% of breast cancer cases diagnosed in the US each year. AutoDiscovery is now being deployed in Providence’s own cloud to support hypothesis generation on protected research and clinical data, with findings validated across independent datasets and lab analyses.